These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17726113)

  • 1. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models.
    Inoue H; Lin L; Lee X; Shao Z; Mendes S; Snodgrass-Belt P; Sweigard H; Engber T; Pepinsky B; Yang L; Beal MF; Mi S; Isacson O
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14430-5. PubMed ID: 17726113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.
    Domanskyi A; Geissler C; Vinnikov IA; Alter H; Schober A; Vogt MA; Gass P; Parlato R; Schütz G
    FASEB J; 2011 Sep; 25(9):2898-910. PubMed ID: 21593433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
    Yin W; Hu B
    Exp Neurol; 2014 Jan; 251():72-83. PubMed ID: 24262204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
    Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leucine-rich repeats of LINGO-1 are not required for self-interaction or interaction with the amyloid precursor protein.
    Stein T; Walmsley AR
    Neurosci Lett; 2012 Feb; 509(1):9-12. PubMed ID: 22133804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
    Zhang L; Huang L; Chen L; Hao D; Chen J
    Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.
    Mi S; Pepinsky RB; Cadavid D
    CNS Drugs; 2013 Jul; 27(7):493-503. PubMed ID: 23681979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of glycogen synthase kinase-3beta and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neurons.
    Zhao XH; Jin WL; Wu J; Mi S; Ju G
    Cell Mol Neurobiol; 2008 Aug; 28(5):727-35. PubMed ID: 18183482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.
    Simunovic F; Yi M; Wang Y; Macey L; Brown LT; Krichevsky AM; Andersen SL; Stephens RM; Benes FM; Sonntag KC
    Brain; 2009 Jul; 132(Pt 7):1795-809. PubMed ID: 19052140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINGO-2 polymorphism and the risk of Parkinson's disease in Taiwan.
    Su FC; Chen CM; Chen YC; Wu YR
    Parkinsonism Relat Disord; 2012 Jun; 18(5):609-11. PubMed ID: 22123311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPBAR1 preserves neurite and synapse of dopaminergic neurons via RAD21-OPCML signaling: Role in preventing Parkinson's disease in mouse model and human patients.
    Zhang Y; Sun X; Zhang Y; Kang Z; Cai L; Ding J; Lu M; Hu G
    Pharmacol Res; 2022 Oct; 184():106459. PubMed ID: 36152741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro.
    Kurowska Z; Brundin P; Schwab ME; Li JY
    Neuroscience; 2014 Jan; 256():456-66. PubMed ID: 24157929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.